四象医学により処方可能な韓方薬肥満治療タブレット製剤の製造方法

Japanese Patent JP7083116

B2

An embodiment of the present invention provides a manufacturing method of an herbal medicinal tablet formulation for treating obesity which is prescribed based on Sasang constitutional medicine, comprises manufacturing a concentrated ephedra powder agent so that an ephedrine content is 3.0-4.0%; determining a weight of the concentrated ephedra powder agent according to each constitution of Sasang constitutional medicine, and manufacturing a side effect-preventing powder agent for each constitution to prevent and suppress side effects according to constitution of Sasang constitutional medicine with respect to the weight of the concentrated ephedra powder agent; mixing the concentrated ephedra powder agent and the side effect-preventing powder agent with a variance of a weight ratio therebetween in consideration of weight, obesity, constitution of Sasang constitutional medicine, and side effects; and tableting the mixture of the prepared ephedra powder agent and side effect-preventing powder agent.

Lim, Young Woo
Ok, Jimyeong
Lee, Eunho
Kim, Young Bin

JP2020536538A

June 10, 2022

December 20, 2018

Click for automatic bibliography generation  

NUBEBE CO.,LTD.
HUMAN HERB CO.,LTD.

A61K36/17; A61K9/28; A61K33/06; A61K33/12; A61K36/076; A61K36/185; A61K36/258; A61K36/282; A61K36/284; A61K36/31; A61K36/346; A61K36/481; A61K36/488; A61K36/49; A61K36/534; A61K36/538; A61K36/54; A61K36/575; A61K36/65; A61K36/708; A61K36/725; A61K36/734; A61K36/736; A61K36/744; A61K36/752; A61K36/804; A61K36/882; A61K36/884; A61K36/894; A61K36/8994; A61K36/9068; A61K47/12; A61K47/38; A61P3/04; A61P43/00

JP2012531446A

KR1020040107544A
KR1020120094989A
KR1020080004420A
KR1020070034561A
KR101672251B1
KR1020090132948A

Fujimoto Partners Corporation

Previous Patent: Organic materials with special optical effects

Next Patent: Oriental medicine obesity treatment tablet preparation that can be prescribed by Sasang Constitution...